PacBio HiFi genome sequencing study flags genetic findings in 1-in-10 subfertility couples

Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.

PACB

0.00
  • Pacific Biosciences announced a preprint from HiFi Solves Sub-fertility Consortium in Asia Pacific, describing its first major multicenter study using HiFi whole genome sequencing in unexplained subfertility or recurrent pregnancy loss.
  • Findings were published ahead of a presentation scheduled for PRISM 2026 in Fukuoka, Japan.
  • Study reported that long-read sequencing produced clinically relevant genetic findings in some couples despite prior standard workups failing to identify causes, supporting use of a single comprehensive workflow to reduce repeat testing and speed reproductive counseling decisions.
  • Consortium plans include expanding recruitment across additional Asia-Pacific centers, testing broader multi-omic approaches, and evaluating more scalable sequencing workflows to improve accessibility and cost-efficiency.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605110905PRIMZONEFULLFEED9717139) on May 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.